Treace Medical Concepts, Inc. (TMCI) Net margin 2019–2025
Treace Medical Concepts, Inc. (TMCI) net profit margin by fiscal year — reported net income divided by reported revenue.
-27.7%FY2025 · since FY2019: -10.8% → -27.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -27.7% | -1.1 pp |
| FY2024 | -26.6% | -0.2 pp |
| FY2023 | -26.5% | +3.7 pp |
| FY2022 | -30.2% | -8.4 pp |
| FY2021 | -21.8% | -15.4 pp |
| FY2020 | -6.4% | +4.4 pp |
| FY2019 | -10.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TMCI financial trends
TMCI RevenueTMCI Net incomeTMCI Gross profitTMCI Gross marginTMCI Operating incomeTMCI Operating marginTMCI Operating cash flowTMCI Free cash flowTMCI Capital expendituresTMCI Return on equityTMCI Stock buybacksTMCI Dividends paidTMCI Total assetsTMCI Total liabilitiesTMCI Shareholders’ equityTMCI overview →